(Q35982902)

11 August 2017

Thyroiditis after treatment with interleukin-2 and interferon alpha-2a (English)

1 reference

11 August 2017

G Pichert

1

1 reference

11 August 2017

L M Jost

2

1 reference

11 August 2017

L Zöbeli

3

1 reference

11 August 2017

B Odermatt

4

1 reference

11 August 2017

G Pedia

5

1 reference

11 August 2017

R A Stahel

6

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 July 1990

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

62

1 reference

11 August 2017

1

1 reference

11 August 2017

100-104

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1990.237

11 August 2017

0 references

cites work

The immunopathology of sequential tumor biopsies in patients treated with interleukin-2. Correlation of response with T-cell infiltration and HLA-DR expression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971759

Hyperinducibility of Ia antigen on astrocytes correlates with strain-specific susceptibility to experimental autoimmune encephalomyelitis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971759

Autoimmune thyroid disease: immunological, pathological, and clinical aspects

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971759

Predominant expression of a T cell receptor V beta gene subfamily in autoimmune encephalomyelitis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971759

6 Goitrous autoimmune thyroiditis (Hashimoto's disease)

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971759

Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin 2 and lymphokine-activated killer cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971759

Influence of tumor necrosis factor-alpha on the modulation by interferon-gamma of HLA class II molecules in human thyroid cells and its effect on interferon-gamma binding

11 July 2018

1 reference

12 December 2020

Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity

1 reference

12 December 2020

Interferon-gamma induces HLA-DR expression by thyroid epithelium

1 reference

12 December 2020

Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon

1 reference

12 December 2020

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

12 December 2020

Enhanced production of gamma-interferon by thyroid-derived T cell clones from patients with Hashimoto's thyroiditis

1 reference

12 December 2020

Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. A phase II clinical trial

1 reference

12 December 2020

Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells

1 reference

12 December 2020

An autoimmune aetiology for hypothyroidism following interferon therapy for breast cancer

1 reference

12 December 2020

A phase II study of interleukin-2 and lymphokine-activated killer cells in patients with metastatic malignant melanoma

1 reference

12 December 2020

Hypothyroidism after interleukin-2 therapy

1 reference

12 December 2020

Tolerance and effectiveness of recombinant interleukin-2 (r-met Hu IL-2 [ala-125]) and lymphokine-activated killer cells in patients with metastatic solid tumors

1 reference

12 December 2020

Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1990.237

1 reference

Dimensions Publication ID

11 August 2017

0 references

1 reference

11 August 2017

PubMed publication ID

2390468

1 reference